Leo Pharma to terminate up to 150 R&D jobs
![Leo Pharma is closing down around 10–15 percent of positions in its R&D unit | Photo: Leo Pharma/PR](https://photos.watchmedier.dk/watchmedier/resize:fill:3840:0:0/plain/https://photos.watchmedier.dk/Images/article13755700.ece/ALTERNATES/schema-16_9/doc7jtizyerbap13dh9k94w.jpg)
Dermatology firm Leo Pharma is closing between 100 and 150 jobs in its research and development unit, which currently counts around 1,000 employees.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
Get full access for you and your coworkers
Start a free company trial todayRelated articles
Layoffs and restructuring will prepare Leo Pharma for IPO
For subscribers
Leo Pharma poaches Novo Nordisk VP to lead US division
For subscribers